BEPROSALIC

This brand name is authorized in Hong Kong, Singapore

Active ingredients

The drug BEPROSALIC contains a combination of these active pharmaceutical ingredients (APIs):

1 Betamethasone UNII 826Y60901U - BETAMETHASONE DIPROPIONATE

Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties. Read about Betamethasone

2 Salicylic acid UNII O414PZ4LPZ - SALICYLIC ACID

Salicylic acid has bacteriostatic and fungicidal actions, but it is its keratolytic properties which are important for this medicinal product. When applied externally it produces slow and painless destruction of the epithelium. Read about Salicylic acid

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D02AF	Salicylic acid preparations	D Dermatologicals → D02 Emollients and protectives → D02A Emollients and protectives
Discover more medicines within D02AF
D07XC01	Betamethasone	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07X Corticosteroids, other combinations → D07XC Corticosteroids, potent, other combinations
Discover more medicines within D07XC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HK	Department of Health Drug Office	Identifier(s): 45900, 51451
Country: SG	Health Sciences Authority	Identifier(s): 09029P, 13316P